Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$980M |
| 2 |
Humana
HUM
|
+$637M |
| 3 |
Apple
AAPL
|
+$620M |
| 4 |
Home Depot
HD
|
+$541M |
| 5 |
Microsoft
MSFT
|
+$539M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$770M |
| 2 |
McDonald's
MCD
|
+$654M |
| 3 |
Cigna
CI
|
+$498M |
| 4 |
Digital Realty Trust
DLR
|
+$430M |
| 5 |
Amazon
AMZN
|
+$429M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.91% |
| 2 | Healthcare | 3.33% |
| 3 | Consumer Discretionary | 2% |
| 4 | Industrials | 1.79% |
| 5 | Financials | 1.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11826
PUT
Silgan Holdings
SLGN
$4.49B
| $43.1K | ﹤0.01% |
1,000
-4,500
| -82% | -$202K |
|
11827
PUT
ProShares Ultra Technology
ROM
$1.32B
| $43.1K | ﹤0.01% |
1,100
-9,500
| -90% | -$412K |
|
11828
PUT
INmune Bio
INMB
$60.2M
| $43.1K | ﹤0.01% |
6,300
+2,600
| +70% | +$21.6K |
|
11829
CALL
Xtrackers S&P 500 ESG ETF
SNPE
$2.79B
| $43.1K | ﹤0.01% |
1,100
+1,000
| +1,000% | +$40.8K |
|
11830
CALL
RLJ Lodging Trust
RLJ
$1.67B
| $43.1K | ﹤0.01% |
4,400
-24,600
| -85% | -$245K |
|
|
BEEMW
11831
DELISTED
Beam Global Warrant
BEEMW
| $43K | ﹤0.01% |
+15,256
| New | +$65.5K |
|
11832
Criteo S.A.
CRTO
$931M
| $43K | ﹤0.01% |
1,473
-7,291
| -83% | -$224K |
|
11833
CALL
Harvard Bioscience
HBIO
$30.3M
| $43K | ﹤0.01% |
1,000
-320
| -24% | -$14.8K |
|
|
DNB
11834
PUT
DELISTED
Dun & Bradstreet
DNB
| $43K | ﹤0.01% |
4,300
-600
| -12% | -$6.63K |
|
11835
PUT
Direxion Daily Junior Gold Miners Index Bear 2X ETF
JDST
$19.8M
| $43K | ﹤0.01% |
26
-11
| -30% | -$15.4K |
|
11836
CALL
ProShares Ultra Materials
UYM
$40.3M
| $42.9K | ﹤0.01% |
2,000
-3,000
| -60% | -$70.3K |
|
11837
PUT
Ingevity
NGVT
$2.64B
| $42.8K | ﹤0.01% |
900
+100
| +13% | +$5.46K |
|
11838
PUT
First Industrial Realty Trust
FR
$8.33B
| $42.8K | ﹤0.01% |
900
+100
| +13% | +$5.15K |
|
11839
CALL
Regis Corp
RGS
$69.3M
| $42.8K | ﹤0.01% |
3,045
+215
| +8% | +$4.74K |
|
11840
PUT
Hooker Furnishings Corp
HOFT
$158M
| $42.8K | ﹤0.01% |
2,200
-300
| -12% | -$6.12K |
|
11841
CALL
EverQuote
EVER
$861M
| $42.7K | ﹤0.01% |
5,900
-46,600
| -89% | -$304K |
|
11842
CALL
Cadre Holdings
CDRE
$1.46B
| $42.6K | ﹤0.01% |
+1,600
| New | +$39.1K |
|
11843
CALL
iShares MSCI Italy ETF
EWI
$1.08B
| $42.6K | ﹤0.01% |
1,400
-12,000
| -90% | -$383K |
|
11844
PUT
Zeta Global
ZETA
$7.29B
| $42.6K | ﹤0.01% |
5,100
-12,900
| -72% | -$106K |
|
11845
Lucid Diagnostics
LUCD
$197M
| $42.6K | ﹤0.01% |
36,375
-26,136
| -42% | -$37.9K |
|
11846
Protalix BioTherapeutics
PLX
$179M
| $42.5K | ﹤0.01% |
+25,614
| New | +$46K |
|
|
SUPV
11847
CALL
Grupo Supervielle
SUPV
$705M
| $42.4K | ﹤0.01% |
19,100
-73,000
| -79% | -$209K |
|
11848
Processa Pharmaceuticals
PCSA
$8.15M
| $42.4K | ﹤0.01% |
332
-234
| -41% | -$44.2K |
|
11849
PUT
Xencor
XNCR
$1.74B
| $42.3K | ﹤0.01% |
2,100
+1,500
| +250% | +$34.1K |
|
|
ONL
11850
CALL
Orion Office REIT
ONL
$164M
| $42.3K | ﹤0.01% |
8,120
-1,700
| -17% | -$10.3K |
|
Similar funds
Ken Griffin's Q3 2023 Portfolio in Review
As of Q3 2023, Ken Griffin held 15,669 positions worth $467B, down 3.6% from $484B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Ken Griffin's Q3 2023 filing shows 1,406 new, 6,433 increased, 6,116 reduced and 1,460 closed positions. Its largest new stake was Arm: 3,445,206 shares worth $184M. The largest sale was Invesco QQQ Trust, an estimated $770M.
By sector, the portfolio is most concentrated in Technology at 3.9% of assets, up from 3% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Ken Griffin's largest Q3 2023 buy was Arm: 3,445,206 shares worth $184M.
- Ken Griffin added most to Activision Blizzard in Q3 2023, an estimated $980M increase.
- Ken Griffin's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $770M.
- Ken Griffin fully exited Coca-Cola Europacific Partners in Q3 2023, selling an estimated $124M.
- Ken Griffin's ten largest holdings make up 33% of its $467B portfolio in Q3 2023.
- Ken Griffin opened 1,406 new positions and closed 1,460 in Q3 2023.
- Ken Griffin's portfolio value fell 3.6% quarter-over-quarter to $467B.
Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.